Gastrointestinal adverse effects are the most common side effects of Wegovy, affecting a significant proportion of users
Treatment stage What may be common What deserves attention Week 1 Nausea, fullness, reduced appetite, bloating, indigestion, diarrhea, constipation, fatigue Repeated vomiting, severe pain, inability to stay hydrated Weeks 2 to 4 Early symptoms may settle, persist, or fluctuate Symptoms interfering with eating, drinking, or daily function Weeks 5 to 8 Symptoms may reappear after clinician-directed dose escalation A significant return or worsening of gastrointestinal symptoms Months 2 to 3 Some patients tolerate treatment more comfortably
Help reduce the risk of major cardiovascular events, such as stroke, heart attack, or death for people with known heart disease who meet the criteria for taking semaglutide
Wondering how these compare to compounded versions
These small movements add up significantly over 14 days